Danijela Vojnović Milutinović

Dr. Danijela Vojnović Milutinović

Institute for Biological Research "Sinisa Stankovic", Belgrade, Beograd, Serbia
orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2014 in The Journal of Nutritional Biochemistry
Verified
Journal Article
Closed access
BBBiljana N. Bursać
Biljana N. Bursać
AVAna D. Vasiljević
Ana D. Vasiljević
NNNatasa Nestorovic
Natasa Nestorovic
NVNataša Veličković
Nataša Veličković
Danijela Vojnović MilutinovićDanijela Vojnović Milutinović
Danijela Vojnović Milutinović
Ana DjordjevicAna Djordjevic
Ana Djordjevic

1 January 2015 in Molecular and Cellular Endocrinology
Verified
Journal Article
Closed access
MNMarina Nikolić
Marina Nikolić
DMDjuro Macut
Djuro Macut
Ana DjordjevicAna Djordjevic
Ana Djordjevic
NVNataša Veličković
Nataša Veličković
NNNatasa Nestorovic
Natasa Nestorovic
Danijela Vojnović MilutinovićDanijela Vojnović Milutinović
Danijela Vojnović Milutinović

24 March 2015 in International Journal of Endocrinology
Verified
Journal Article
Open access
PDF file
DMDjuro Macut
Djuro Macut
MBMarina Bačević
Marina Bačević
IBIvana Božić-Antić
Ivana Božić-Antić
DMDjuro Macut
Djuro Macut
MČMilorad Čivčić
Milorad Čivčić
TŠTijana Šukilović
Tijana Šukilović
Background. Women with polycystic ovary syndrome (PCOS) could develop subclinical atherosclerosis during life.Purpose. To analyze cardiovascular risk (CVR) factors and their relation to clinical markers of cardiovascular disease (CVD) in respect to their age.Material and Methods. One hundred women with PCOS (26.32±5.26years, BMI:24.98±6.38 kg/m2) were compared to 50 respective controls. In all subjects, total cholesterol (TC), HDL-C, LDL-C, triglycerides, TC/HDL-C and TG/HDL-C ratios, glucose, insulin and HOMA index, waist-to-hip ratio (WHR), systolic and diastolic blood pressure (SBP and DBP, resp.), and carotid intima-media thickness (CIMT) were analyzed in respect to their age and level of androgens.Results. PCOS over 30 years had higher WHR (P=0.008), SBP (P<0.001), DBP (P<0.001), TC (P=0.028), HDL-C (P=0.028), LDL-C (P=0.045), triglycerides (P<0.001), TC/HDL-C (P<0.001), and triglycerides/HDL-C (P<0.001) and had more prevalent hypertension and pronounced CIMT on common carotid arteries even after adjustment for BMI (P=0.005and 0.036, resp.). TC/HDL-C and TG/HDL-C were higher in PCOS with the highest quintile of FAI in comparison to those with lower FAI (P=0.045and 0.034, resp.).Conclusions. PCOS women older than 30 years irrespective of BMI have the potential for early atherosclerosis mirrored through the elevated lipids/lipid ratios and through changes in blood pressure.

1 October 2021 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
PDF file
JBJelica Bjekić-Macut
Jelica Bjekić-Macut
TVTamara Vukašin
Tamara Vukašin
ZVZelija Velija-Ašimi
Zelija Velija-Ašimi
ABAzra Bureković
Azra Bureković
Marija ZdravkovićMarija Zdravković
Marija Zdravković
George MastorakosGeorge Mastorakos
George Mastorakos
Polycystic ovary syndrome (PCOS) is a frequent endocrine disease in women during the reproductive period. It is considered a complex metabolic disorder with long-term metabolic, as well as reproductive consequences. Main pathophysiological pathways are related to the increased androgen levels and insulin resistance. Nowadays, genetic origins of PCOS are acknowledged, with numerous genes involved in the pathogenesis of hyperandrogenemia, insulin resistance, inflammation, and disturbed folliculogenesis. Rotterdam diagnostic criteria are most widely accepted and four PCOS phenotypes have been recognized. Metabolic abnormalities are more common in phenotypes 1 and 2. Women with classic PCOS are more obese and typically have the central type of obesity, more prevalently displaying dyslipidemia, insulin resistance, and metabolic syndrome that could be associated with an increased risk of cardiovascular complications during life. Heterogeneity of phenotypes demands an individualized approach in the treatment of women with PCOS. Metabolic therapies involve a lifestyle intervention followed by the introduction of insulin sensitizers including metformin and inositols, glucagon-like peptide 1 receptor agonists (GLP-1 RA), as recently sodium-glucose cotransporter-2 (SGLT2) inhibitors. The addition of an insulin sensitizer to the standard infertility therapy such as clomiphene citrate improves ovulation and pregnancy rates. Our current review analyzes the contemporary knowledge of PCOS etiology and etiopathogenesis, its cardiometabolic risks and their outcomes, as well as therapeutic advances for women with PCOS.

8 November 2011 in Experimental and Clinical Endocrinology & Diabetes
Verified
Journal Article
Closed access
PDF file
Danijela Vojnović MilutinovićDanijela Vojnović Milutinović
Danijela Vojnović Milutinović
DMD. Macut
D. Macut
IBI. Božić
I. Božić
JNJ. Nestorov
J. Nestorov
SDS. Damjanović
S. Damjanović
GMGordana Matić
Gordana Matić
Molecular mechanisms underlying pathophysiology of polycystic ovary syndrome (PCOS), especially those related to cortisol signaling, are poorly understood. We hypothesized that modulation of glucocorticoid receptor (GR) expression and function, may underlie possible PCOS-related impairment of feedback inhibition of hypothalamic-pituitary-adrenocortical (HPA) axis activity and thus contribute to increased adrenal androgen production in women with PCOS. 24 normal-weight and 31 obese women with PCOS were compared to 25 normal-weight controls. Fasting blood samples were collected for measurements of serum concentrations of dehydroepiandrosterone sulfate, testosterone, sex hormone-binding globulin, insulin, basal cortisol and cortisol after oral administration of 0.5 mg dexamethasone. Concentrations of GR mRNA, GR protein, mineralocorticoid receptor (MR) protein and heat shock proteins (Hsps), as well as the number of GR per cell (Bmax) and its equilibrium dissociation constant (KD) were measured in isolated peripheral blood mononuclear cells. An increase in HPA axis sensitivity to dexamethasone, an elevation of the GR protein concentration, and unaltered receptor functional status were found in both normal-weight and obese women with PCOS vs. healthy controls. Lymphocyte MR, Hsp90 and Hsp70 concentrations, and MR/GR ratio were similar in all groups. Correlation between Bmax and KD was weaker in the group of obese women with PCOS than in the other 2 groups. The results did not confirm the initial hypothesis, but imply that PCOS is associated with increased GR protein concentration and HPA axis sensitivity to dexamethasone.

30 May 2023 in Biomedicines
Verified
Journal Article
Open access
PDF file
Bojana MićićBojana Mićić
Bojana Mićić
Ana DjordjevicAna Djordjevic
Ana Djordjevic
NVNataša Veličković
Nataša Veličković
SKSanja Kovacevic
Sanja Kovacevic
TMTeodora Martić
Teodora Martić
Danijela Vojnović MilutinovićDanijela Vojnović Milutinović
Danijela Vojnović Milutinović
Polycystic ovary syndrome (PCOS) is a common endocrinopathy in women of reproductive age, often associated with obesity and insulin resistance. Childhood obesity is an important predisposing factor for the development of PCOS later in life. Being particularly interested in the interplay between prepubertal obesity and hyperandrogenemia, we investigated the effects of early postnatal overfeeding, accomplished by reducing litter size during the period of suckling, on energy sensing and insulin signaling pathways in the gastrocnemius muscle of a rat model of PCOS-induced by 5α-dihydrotestosterone (DHT). The combination of overfeeding and DHT treatment caused hyperinsulinemia and decreased systemic insulin sensitivity. Early postnatal overfeeding induced defects at critical nodes of the insulin signaling pathway in skeletal muscle, which was associated with reduced glucose uptake in the presence of hyperandrogenemia. In this setting, under a combination of overfeeding and DHT treatment, skeletal muscle switched to mitochondrial β-oxidation of fatty acids, resulting in oxidative stress and inflammation that stimulated AMP-activated protein kinase (AMPK) activity and its downstream targets involved in mitochondrial biogenesis and antioxidant protection. Overall, a combination of overfeeding and hyperandrogenemia resulted in a prooxidative and insulin-resistant state in skeletal muscle. This was accompanied by the activation of AMPK, which could represent a potential therapeutic target in insulin-resistant PCOS patients.